By targeting these three pathways, reta offers a comprehensive approach to weight management and metabolic health:

• Significant Weight Loss: In phase 2 and 3 clinical trials, participants on the highest doses lost an average of 24% to nearly 29% of their starting body weight over 48 to 68 weeks.
• Improved Glycemic Control: It helps regulate blood sugar levels effectively, with studies showing many participants with prediabetes returned to normal blood sugar levels.
• Reduced Liver Fat: Research indicates it can significantly reduce fat buildup in the liver, potentially treating conditions like metabolic dysfunction-associated steatotic liver disease (MASLD).
• Cardiovascular Health: Early data suggests improvements in blood pressure and cholesterol levels, which may reduce cardiovascular risk factors.